EGF816 Exerts Anticancer Effects in Non–Small Cell Lung Cancer by Irreversibly and Selectively Targeting Primary and Acquired Activating Mutations in the EGF Receptor

Overview of attention for article published in Cancer Research, March 2016

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
Among the highest-scoring outputs from this source (#26 of 19,106)
High Attention Score compared to outputs of the same age (99th percentile)
High Attention Score compared to outputs of the same age and source (99th percentile)

Mentioned by

news: 67 news outlets
policy: 1 policy source
twitter: 2 X users

patent: 6 patents
reddit: 1 Redditor

Citations

dimensions_citation: 109 Dimensions

Readers on

mendeley: 71 Mendeley

Summary News Policy documents X Patents Reddit Dimensions citations

So far, Altmetric has seen 69 news stories from 67 outlets.

Crown Bioscience Announces the Establishment of Unique EGFR-mutated Non-Small Cell Lung Cancer Models

BioMed Reports, 10 May 2016

CrownBio's newly established models have been trialed with a range of EGFR inhibitors – including I, II, and III generation…

Crown Bioscience Announces the Establishment of Unique EGFR-mutated Non-Small Cell Lung Cancer Models

NewsOn6, 10 May 2016

SOURCE Crown Bioscience Inc. SANTA CLARA, Calif. EGFR is an important molecular target for drug treatment; however, the lack of…

News story from Finanz Nachrichten on Tuesday 10 May 2016

Finanz Nachrichten, 10 May 2016

Crown Bioscience Announces the Establishment of Unique EGFR-mutated Non-Small Cell Lung Cancer Models

2 News, 10 May 2016

SOURCE Crown Bioscience Inc. SANTA CLARA, Calif. EGFR is an important molecular target for drug treatment; however, the lack of…

This page shows the most recent news stories that mention this research output.

Click here to find out how to access more activity, including 65 additional news stories.